XML 58 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Income (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Revenue:        
Product revenue $ 237,515 $ 217,322 $ 456,907 $ 423,089
Service revenue 152,607 135,261 293,418 261,599
Total revenue 390,122 352,583 750,325 684,688
Cost of Revenue:        
Cost of product revenue 86,956 79,842 164,998 153,993
Cost of service revenue 84,648 75,043 164,712 149,025
Total cost of revenue 171,604 154,885 329,710 303,018
Gross profit 218,518 197,698 420,615 381,670
Expenses:        
Sales and marketing 68,020 57,896 135,868 117,294
General and administrative 41,846 38,858 82,935 80,488
Research and development 25,433 22,181 48,547 43,939
Income from operations 83,219 78,763 153,265 139,949
Interest expense (2,965) (1,179) (5,739) (2,014)
Interest income 488 444 959 889
Income before provision for income taxes 80,742 78,028 148,485 138,824
Provision for income taxes 23,498 24,029 44,648 39,959
Net income 57,244 53,999 103,837 98,865
Less: Net income attributable to noncontrolling interest 26 4 34 11
Net income attributable to IDEXX Laboratories, Inc. stockholders $ 57,218 $ 53,995 $ 103,803 $ 98,854
Earnings per Share:        
Basic $ 1.12 $ 1.01 $ 2.02 $ 1.83
Diluted $ 1.10 $ 0.99 $ 1.99 $ 1.80
Weighted Average Shares Outstanding:        
Basic 51,125,000 53,670,000 51,369,000 54,125,000
Diluted 51,795,000 54,386,000 52,080,000 54,955,000